...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and sigma receptor antagonists.
【24h】

Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and sigma receptor antagonists.

机译:合成4-(氨基烷基)取代的1,3-二恶烷作为有效的NMDA和sigma受体拮抗剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Elongation of the distance between the oxygen heterocycle and the basic amino moiety or ring expansion of the oxygen heterocycle of the NMDA receptor antagonists dexoxadrol and etoxadrol led to compounds with promising NMDA receptor affinity. Herein the combination of both structural features, i.e. elongation of the O-heterocycle--amine distance with a 1,3-dioxane ring is envisaged. The synthesis of aminoethyl-1,3-dioxanes 13, 22, 23 and 29 was performed by transacetalization of various acetals with pentane-1,3,5-triol, activation of the remaining free OH moiety with tosyl chloride and subsequent nucleophilic substitution. The corresponding 3-aminopropyl derivatives 33-35 were prepared by substitution of the tosylates with KCN and LiAlH4 reduction. The highest NMDA receptor affinity was found for 1,3-dioxanes with a phenyl and an ethyl residue at the acetalic position (23) followed by diphenyl (22) and monophenyl derivatives (13). Generally the NMDA affinity of primary amines is higher than the NMDA affinity of secondary and tertiary amines. Altogether the primary amine 23a (Ki=24 nM) represents the most promising NMDA receptor antagonist of this series exceeding the NMDA affinity of the mono-homologues (2-aminoethyl)-1,3-dioxolanes (3,4) and (aminomethyl)-1,3-dioxanes (5,6). Whereas the primary amine 23a turned out to be selective against sigma1 and sigma2 receptors the benzylamine 13d was identified as potent (Ki=19 nM) and selective sigma1 antagonist, which showed extraordinarily high antiallodynic activity in the capsaicin assay.
机译:氧杂环与NMDA受体拮抗剂右旋沙特洛和乙氧磷的氧杂环基的碱性氨基部分之间的距离延长或氧杂环的环扩展导致具有希望的NMDA受体亲和力的化合物。在此,设想了两种结构特征的组合,即具有1,3-二恶烷环的O-杂环-胺距离的延长。氨基乙基-1,3-二恶烷13、22、23和29的合成是通过将各种缩醛与戊烷1,3,5-三醇进行缩醛化,用甲苯磺酰氯活化剩余的游离OH部分并随后进行亲核取代来进行的。相应的3-氨基丙基衍生物33-35是通过用KCN和LiAlH 4还原取代甲苯磺酸酯而制备的。对于在缩醛位置(23)具有苯基和乙基残基的1,3-二恶烷,发现最高的NMDA受体亲和力,其次是二苯基(22)和单苯基衍生物(13)。通常,伯胺的NMDA亲和力高于仲胺和叔胺的NMDA亲和力。总的来说,伯胺23a(Ki = 24 nM)代表了该系列中最有前途的NMDA受体拮抗剂,超过了单同源物(2-氨基乙基)-1,3-二氧戊环(3,4)和(氨基甲基)的NMDA亲和力-1,3-二恶烷(5,6)。伯胺23a对sigma1和sigma2受体具有选择性,而苄胺13d被确定为有效的(Ki = 19 nM)和选择性的sigma1拮抗剂,在辣椒素分析中显示出极高的抗痛觉过敏活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号